The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer

Viruses

Volumn 7, Issue 4, 2015, Pages 1871-1901

  Moens, Ugo ^a   Rasheed, Kashif ^a   Abdulsalam, Ibrahim ^a   Sveinbjørnsson, Baldur ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Autophagy; Exosomes; Glucose; Inflammation; MicroRNA; Polyomavirus; Therapy

Indexed keywords

CELL SURFACE MARKER; CHEMOKINE; CYTOKINE; DEOXYGLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; MICRORNA; NIVOLUMAB; TUMOR ANTIGEN; TUMOR SUPPRESSOR PROTEIN; ONCOPROTEIN; TUMOR MARKER; VIRUS T ANTIGEN;

ANGIOGENESIS; APOPTOSIS; AUTOPHAGY; BK VIRUS; CANCER RISK; CARCINOGENESIS; DNA BINDING MOTIF; EXOSOME; GENE SILENCING; HOMEOSTASIS; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNE SYSTEM; JC VIRUS; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; METASTASIS; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; VACCINATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOGENICITY; PATHOLOGY; POLYOMAVIRUS; VIROLOGY;

ANIMALIA; MAMMALIA; POLYOMAVIRUS;

ANTIGENS, VIRAL, TUMOR; BIOMARKERS, TUMOR; HUMANS; NEOPLASMS; ONCOGENE PROTEINS; POLYOMAVIRUS;

EID: 84928962914     PISSN: 19994915     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7041871     Document Type: Review

References (219)

1. Johne, R.; Buck, C.B.; Allander, T.; Atwood, W.J.; Garcea, R.L.; Imperiale, M.J.; Major, E.O.; Ramqvist, T.; Norkin, L.C. Taxonomical developments in the family Polyomaviridae. Arch. Virol. 2011, 156, 1627-1634.
2. Peretti, A.; FitzGerald, P.C.; Bliskovsky, V.; Pastrana, D.V.; Buck, C.B. Genome Sequence of a Fish-Associated Polyomavirus, Black Sea Bass (Centropristis striata) Polyomavirus 1. Genome Announc. 2015, 3, e01476-14.
3. DeCaprio, J.A.; Imperiale, M.J.; Major, E.O. Polyomaviruses. In Fields Virology, 6th ed.; Knipe, D.M., Howley, P.M., Eds.; Lippincott Williams & Wilkins, and Wolters Kluwer: Philadelphia, PA, USA, 2013; Volume 2, pp. 1633-1661.
4. Carter, J.J.; Daugherty, M.D.; Qi, X.; Bheda-Malge, A.; Wipf, G.C.; Robinson, K.; Roman, A.; Malik, H.S.; Galloway, D.A. Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes. Proc. Natl. Acad. Sci. USA 2013, 110, 12744-12749.
5. Schowalter, R.W.; Buck, C.B. The merkel cell polyomavirus minor capsid protein. PLOS Pathog. 2013, 9, e1003558.
6. Ehlers, B.; Moens, U. Genome analysis of non-human primate polyomaviruses. Infect. Genet. Evol. 2014, 26, 283-294.
7. Fulghieri, C.; Bloom, S. SarahElizabeth Stewart. Emerg. Infect. Dis. 2014, 20, 893-895.
8. Sweet, B.H.; Hilleman, M.R. The vacuolating virus, SV40. Proc. Soc. Exp. Biol. Med. 1960, 105, 420-427.
9. Cheng, J.; DeCaprio, J.A.; Fluck, M.M.; Schaffhausen, B.S. Cellular transformation by Simian Virus 40 and Murine Polyomavirus T antigens. Semin. Cancer Biol. 2009, 19, 218-228.
10. An, P.; Sáenz Robles, M.T.; Pipas, J.M. Large T antigens of polyomaviruses: Amazing molecular machines. Annu. Rev. Microbiol. 2012, 66, 213-236.
11. Valis, J.D.; Strandberg, J.D.; Shah, K.V. Transformation of hamster kidney cells by simian papovavirus SA12. Proc. Soc. Exp. Biol. Med. 1979, 160, 208-212.
12. Bastien, C.; Feunteun, J. The hamster polyomavirus transforming properties. Oncogene 1988, 2, 129-135.
13. Chen, J.D.; Neilson, K.; van Dyke, T. Lymphotropic papovavirus early region is specifically regulated in transgenic mice and efficiently induces neoplasia. J. Virol. 1989, 63, 2204-2214.
14. Dela Cruz, F.N., Jr.; Giannitti, F.; Li, L.; Woods, L.W.; del Valle, L.; Delwart, E.; Pesavento, P.A. Novel polyomavirus associated with brain tumors in free-ranging raccoons, western United States. Emerg. Infect Dis. 2013, 19, 77-84.
15. Simmons, J.H.; Riley, L.K.; Franklin, C.L.; Besch-Williford, C.L. Hamster polyomavirus infection in a pet Syrian hamster (Mesocricetus auratus). Vet. Pathol. 2001, 38, 441-446.
16. Colegrove, K.M.; Wellehan, J.F., Jr.; Rivera, R.; Moore, P.F.; Gulland, F.M.; Lowenstine, L.J.; Nordhausen, R.W.; Nollens, H.H. Polyomavirus infection in a free-ranging California sea lion (Zalophus californianus) with intestinal T-cell lymphoma. J. Vet. Diagn. Invest. 2010, 22, 628-632.
17. Stevens, H.; Bertelsen, M.F.; Sijmons, S.; van Ranst, M.; Maes, P. Characterization of a novel polyomavirus isolated from a fibroma on the trunk of an African elephant (Loxodonta africana). PLOS ONE 2013, 8, e77884.
18. Johne, R.; Müller, H. Polyomaviruses of birds: Etiological agents of inflammatory diseases in a tumor virus family. J. Virol. 2007, 81, 11554-11559.
19. Gardner, S.D.; Field, A.M.; Coleman D.V.; Humle, B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971, 1, 1253-1257.
20. Padgett, B.L.; Walker, D.L.; ZuRhein, G.M.; Eckroade, R.J.; Dessel, B.H. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971, 1, 1257-1260.
21. Atkin, S.J.; Griffin, B.E.; Dilworth, S.M. Polyoma virus and simian virus 40 as cancer models: History and perspectives. Semin. Cancer Biol. 2009, 19, 211-217.
22. Pipas, J.M. SV40: Cell transformation and tumorigenesis. Virology 2009, 384, 294-303.
23. Allander, T.; Andreasson, K.; Gupta, S.; Bjerkner, A.; Bogdanovic, G.; Persson, M.A.; Dalialis, T.; Ramqvist, T.; Andersson, B. Identification of a third human polyomavirus. J. Virol. 2007, 81, 4130-4136.
24. Gaynor, A.; Nissen, M.D.; Whiley, D.M.; Mackay, I.M.; Lambert, S.B.; Wu, G.; Brennan, D.C.; Storch, G.A.; Wang, D. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLOS Pathog. 2007, 3, 595-604.
25. Feng, H.; Shuda, M.; Chang, Y.; Moore, P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319, 1096-1100.
26. Schowalter, R.M.; Pastrana, D.V.; Pumphrey, K.A.; Moyer, A.L.; Buck, C.B. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010, 7, 509-515.
27. van der Meijden, E.; Janssens, R.W.; Lauber, C.; Bouwens Bavinck, J.N.; Gorbalenya, A.E.; Feltkamp, M.C. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLOS Pathog. 2010, 6, e1001024.
28. Scuda, N.; Hofmann, J.; Calvignac-Spencer, S.; Ruprecht, K.; Liman, P.; Kühn, J.; Hengel, H.; Ehlers, B. A novel human polyomavirus closely related to the African green monkey-derived lymphotropic polyomavirus. J. Virol. 2011, 85, 4586-4590.
29. Sauvage, V.; Foulongne, V.; Cheval, J.; Pariente, K.; Le Gouil, M.; Burguiere, A.M.; Manuguerra, J.C.; Caro, V.; Eloit, M. Human polyomavirus related to the green monkey lymphotropic polyomavirus. Emerg. Infect. Dis. 2011, 17, 1364-1370.
30. Buck, C.B.; Phan, G.Q.; Raiji, M.T.; Murphy, P.M.; McDermott, D.H.; McBride, A.A. Complete genome sequence of a tenth human polyomavirus. J. Virol. 2012, 86, 10887.
31. Siebrasse, E.A.; Reyes, A.; Lim, E.S.; Zhao, G.; Mkakosya, R.S.; Manary, M.J.; Gordon, J.I.; Wang, D. Identification of MW polyomavirus, a novel polyomavirus in human stool. J. Virol. 2012, 86, 10321-10326.
32. Yu, G.; Greninger, A.L.; Isa, P.; Phan, T.G.; Martinez, M.A.; Luz Sanchez, M.; Contreras, J.F.; Santos-Preciado, J.I.; Parsonnet, J.; Miller, S., et al. Discovery of a novel polyomavirus in acute diarrheal samples from children. PLOS ONE 2012, 7, e49449.
33. Lim, E.S.; Reyes, A.; Antonio, M.; Saha, D.; Ikumapayi, U.N.; Adeyemi, M.; Stine, O.C.; Skelton, R.; Brennan, D.C.; Mkakosya, R.S., et al. Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology 2013, 436, 295-303. Erratum in: Virology 2013, 439, 163-164.
34. Korup, S.; Rietscher, J.; Calvignac-Spencer, S.; Trusch, F.; Hofmann, J.; Moens, U.; Sauer, I.; Voight, S.; Schmuck, R.; Ehlers, B. Identification of a novel human polyomavirus in organs of the gastrointestinal tract. PLOS ONE 2013, 8, e58021.
35. Mishra, N.; Pereira, M.; Rhodes, R.H.; An, P.; Pipas, J.M.; Jain, K.; Kapoor, A.; Briese, T.; Faust, P.L.; Lipkin, W.I. Identification of a novel polyomavirus in a pancreatic transplant recipient with retinal blindness and vascular myopathy. J. Infect. Dis. 2014, 210, 1595-1599.
36. Moens, U.; van Ghelue, M.; Song, X.; Ehlers, B. Serological cross-reactivity between human polyomaviruses. Rev. Med. Virol. 2013, 23, 250-264.
37. Lim, E.S.; Meinerz, N.M.; Primi, B.; Wang, D.; Garcea, R.L. Common exposure to STL polyomavirus during childhood. Emerg. Infect. Dis. 2014, 20, 1559-1561.
38. Nicol, J.T.; Leblond, V.; Arnold, F.; Guerra, G.; Mazzoni, E.; Tognon, M.; Coursaget, P.; Touzé, A. Seroprevalence of human Malawi polyomavirus. J. Clin. Microbiol. 2014, 52, 321-323.
39. Moens, U.; van Ghelue, M.; Johannessen, M. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol. Life Sci. 2007, 64, 1656-1678.
40. Borchert, S.; Czech-Sioli, M.; Neumann, F.; Schmidt, C.; Wimmer, P.; Dobner, T.; Grundhoff, A.; Fischer, N. High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens. J. Virol. 2014, 88, 3144-3160.
41. Verhaegen, M.E.; Mangelberger, D.; Harms, P.W.; Vozheiko, T.D.; Weick, J.W.; Wilbert, D.M.; Saunders, T.L.; Ermilov, A.N.; Bichakjian, C.K.; Johnson, T.M.; Imperiale, M.J.; Dlugosz, A.A. Merkel cell polyomavirus small t antigen is oncogenic in transgenic mice. J. Invest. Dermatol. 2014, doi:10.1038/jid.2014.446.
42. Spurgeon, M.E.; Cheng, J.; Bronson, R.T.; Lambert, P.F.; DeCaprio, J.A. Tumorigenic activity of Merkel cell polyomavirus T antigens expressed in the stratified epithelium of mice. Cancer Res. 2015, doi:10.1158/0008-5472.CAN-14-2425.
43. Chang, Y.; Moore, P.S. Merkel cell carcinoma: A virus-induced human cancer. Annu. Rev. Pathol. 2012, 7, 123-144.
44. Moens, U.; Johannessen, M. Human polyomaviruses and cancer: Expanding repertoire. J. Dtsch. Dermatol. Ges. 2008, 6, 704-708.
45. Abend, J.R.; Jiang, M.; Imperiale, M.J. BK virus and cancer: Innocent until proven guilty. Semin. Cancer Biol. 2009, 19, 252-260.
46. Maginnis, M.S.; Atwood, W.J. JC virus: An oncogenic virus in animals and humans? Semin. Cancer Biol. 2009, 19, 261-269.
47. Enam, S.; Del Valle, L.; Lara, C.; Gan, D.D.; Ortiz-Hidalgo, C.; Palazzo, J.P.; Khalili, K. Association of human polyomavirus JCV with colon cancer: Evidence for interaction of viral T-antigen and beta-catenin. Cancer Res. 2002, 62, 7093-7101.
48. Bulut, Y.; Ozdemir, E.; Ozercan, H.I.; Etem, E.O.; Aker, F.; Toraman, Z.A.; Seyrek, A.; Firdolas, F. Potential relationship between BK virus and renal cell carcinoma. J. Med. Virol. 2013, 85, 1085-1089.
49. Delbue, S.; Ferrante, P.; Provenzano, M. Polyomavirus BK and prostate cancer: An unworthy scientific effort? Oncoscience 2014, 1, 296-303.
50. Carluccio, S.; Signorini, L.; Elia, F.; Villani, S.; Delbue, S.; Ferrante, P. A potential linkage between the JC and BK polyomaviruses and brain and urinary tract tumors: A review of the literature. Adv. Tumor. Virol. 2014, 4, 17-24.
51. zur Hausen, H. Red meat consumption and cancer: Reasons to suspect involvement of bovine infectious factors in colorectal cancer. Int. J. Cancer 2012, 130, 2475-2483.
52. Zhang, W.; Li, L.; Deng, X.; Kapusinszky, B.; Delwart, E. What is for dinner? Viral metagenomics of US store bought beef, pork and chicken. Virology 2014, 468, 303-310.
53. Peretti, A.; FitzGerald, P.C.; Bliskovsky, V.; Buck, C.B.; Pastrana, D.V. Hamburger polyomaviruses. J. Gen. Virol. 2015, doi:10.1099/vir.0.000033
54. Schrama, D.; Groesser, L.; Ugurel, S.; Hafner, C.; Pastrana, D.V.; Buck, C.B.; Cerroni, L.; Theiler, A.; Becker, J.C. Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferation. JAMA Dermatol. 2014, 150, 1180-1186.
55. Ramqvist, T.; Nordfors, C.; Dalianis, T.; Ragnarsson-Olding, B. DNA from human polyomaviruses, TSPyV, MWPyV, HPyV6, 7, and 9 was not detected in primary mucosal melanomas. Anticancer Res. 2014, 34, 639-643.
56. Imajoh, M.; Hashida, Y.; Nakajima, H.; Sano, S.; Daibata, M. Prevalence and viral DNA loads of three novel human polyomaviruses in skin cancers from Japanese patients. J. Dermatol. 2013, 40, 657-660.
57. Scola, N.; Wieland, U.; Silling, S.; Altmeyer, P.; Stücker, M.; Kreuter, A. Prevalence of human polyomaviruses in common and rare types of non-Merkel cell carcinoma skin cancer. Br. J. Dermatol. 2012, 167, 1315-1320.
58. Antonsson, A.; Bialasiewicz, S.; Rockett, R.J.; Jacob, K.; Bennett, I.C.; SLoots, T.P. Exploring the Prevalence of Ten Polyomaviruses and Two Herpes Viruses in Breast Cancer. PLOS ONE 2012, 7, e39842.
59. Foulongne, V.; Sauvage, V.; Hebert, C.; Dereure, O.; Cheval, J.; Gouilh, M.A.; Pariente, K.; Segondy, M.; Burguière, A.; Manuguerra, J.C.; Caro, V.; Eloit, M. Human skin microbiota: High diversity of DNA viruses identified on the human skin by high throughput sequencing. PLOS ONE 2012, 7, e38499.
60. Giraud, G.; Ramqvist, T.; Ragnarsson-Olding, B.; Dalialis, T. DNA from BK virus and JC virus and from KI, WU, and MC polyomaviruses as well as from simian virus 40 is not detected in non-UV-light-associated primary malignant melanomas of mucous membranes. J. Clin. Microbiol. 2008, 46, 3595-3598.
61. Bzhalava, D.; Johansson, H.; Ekström, J.; Faust, H.; Möller, B.; Eklund, C.; Nordin, P.; Stenquist, B.; Paoli, J.; Persson, B.; Forslund, O.; Dillner, J. Unbiased approach for virus detection in skin lesions. PLOS ONE 2013, 8, e655953.
62. Imajoh, M.; Hashida, Y.; Taniguchi, A.; Kamioka, M.; Daibata, M. Novel human polyomaviruses, Merkel cell polyomavirus and human polyomavirus 9, in Japanese chronic lymphocytic leukemia cases. J. Hematol. Oncol. 2012, 5, e25.
63. Kreuter, A.; Silling, S.; Dewan, M.; Stücker, M.; Wieland, U. Evaluation of 4 recently discovered human polyomaviruses in primary cutaneous B-cell and T-cell lymphoma. Arch. Dermatol. 2011, 147, 1449-1451.
64. Duncavage, E.J.; Pfeifer, J.D. Human polyomaviruses 6 and 7 are not detectable in Merkel cell polyomavirus-negative Merkel cell carcinoma. J. Cutan. Pathol. 2011, 38, 790-796.
65. Kanitakis, J.; Kazem, S.; van Der Meijden, E.; Feltkamp, M. Absence of the trichodysplasia spinulosa-associated polyomavirus in human pilomatricomas. Eur. J. Dermatol. 2011, 21, 453-454.
66. Babakir-Mina, M.; Ciccozzi, M.; Campitelli, L.; Aquaro, S.; Lo Coco, A.; Perno, C.F.; Ciotti, M. Identification of the novel KI Polyomavirus in paranasal and lung tissues. J. Med. Virol. 2009, 81, 558-561.
67. Giraud, G.; Ramqvist, T.; Pastrana, D.V.; Pavot, V.; Lindau, C.; Kogner, P.; Orrego, A.; Buck, C.B.; Allander, T.; Holm, S.; Gustavsson, B.; Dalianis, T. DNA from KI, WU and Merkel cell polyomavirus is not detected in childhood central nervous system tumors or neuroblastomas. PLOS ONE 2009, 4, e8239.
68. Gustafsson, B.; Honkaniemi, E.; Goh, S.; Giraud, G.; Forestier, E.; von Döbeln, U.; Allander, T.; Dalianis, T.; Bogdanovic, G. KI, WU, and Merkel cell polyomavirus DNA was not detected in guthrie cards of children who later developed acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 2012, 34, 364-367.
69. Teramoto, S.; Kaiho, M.; Takano, Y.; Endo, R.; Kikuta, H.; Sawa, H.; Ariga, T.; Ishiguro, N. Detection of KI polyomavirus and WU polyomavirus DNA by real-time polymerase chain reaction in nasopharyngeal swabs and in normal lung and lung adenocarcinoma tissues. Microbiol. Immunol. 2011, 55, 525-530.
70. Duncavage, E.J.; Le, B.M.; Wang, D.; Pfeifer, J.D. Merkel cell polyomavirus: A specific marker for Merkel cell carcinoma in histologically similar tumors. Am. J. Surg. Pathol. 2009, 33, 1771-1777.
71. Schmitt, M.; Höfler, D.; Koleganova, N.; Pawlita, M. Human polyomaviruses and other human viruses in neuroendocrine tumors. Cancer Epidemiol. Biomarkers Prev. 2011, 20, 1558-1561.
72. Du-Thanh, A.; Foulongne, V.; Guillot, B.; Dereure, O. Recently discovered human polyomaviruses in lesional and non-lesional skin of patients with primary cutaneous T-cell lymphomas. J. Dermatol. Sci. 2013, 71, 140-142
73. Hashida, Y.; Taniguchi, A.; Yawata, T.; Hosokawa, S.; Murakami, M.; Hiroi, M.; Ueba, T.; Daibata, M. Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects. Infect Agent Cancer 2015, 10, e3.
74. Rennspiess, D.; Pujari, S.; Keijzers, M.; Abdul-Hamid, M.A.; Hochstenbag, M.; Dingemans, A.; Kurz, A.K.; Speel, E.; Haugg, A.; Pastrana, D.V., et al. Detection of Human Polyomavirus 7 in human thymic epithelial tumors. J. Thorac. Oncol. 2015, 10, 360-366.
75. Gjoerup, O.; Chang, Y. Update on human polyomaviruses and cancer. Adv. Cancer Res. 2010, 106, 1-51.
76. DeCaprio, J.A.; Garcea, R.L. A cornucopia of human polyomaviruses. Nat. Rev. Microbiol. 2013, 11, 264-276.
77. Spurgeon, M.E.; Lambert, P.F. Merkel cell polyomavirus: A newly discovered human virus with oncogenic potential. Virology 2013, 435, 118-130.
78. Moore, P.S.; Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumor virology. Nat. Rev. Cancer 2010, 10, 878-889.
79. Dunn, G.P.; Bruce, A.T.; Ikeda, H.; Old, L.J.; Schreiber, R.D. Cancer immunoediting: From immunosurveillance to tumor escape. Nat. Immunol. 2002, 3, 991-998.
80. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674.
81. Banerjee, A.; Vasanthakumar, A.; Grigoriadis, G. Modulating T regulatory cells in cancer: How close are we? Immunol. Cell Biol. 2013, 91, 340-349.
82. Vossen, M.T.; Westerhout, E.M.; Söderberg N.C.; Wiertz, E.J. Viral immune evasion: A masterpiece of evolution. Immunogenetics 2002, 54, 527-542.
83. Bhatia, S.; Afanasiev, O.; Nghiem, P. Immunobiology of Merkel cell carcinoma: Implications for immunotherapy of a polyomavirus-associated cancer. Curr. Oncol. Rep. 2011, 13, 488-497.
84. Shahzad, N.; Shuda, M.; Gheit, T.; Kwun, H.J.; Cornet, I.; Saidj, D.; Zannetti, C.; Hasan, U.; Chang, Y.; Moore, P.S., et al. The T Antigen Locus of Merkel Cell Polyomavirus downregulates Human Toll-Like Receptor 9 Expression. J. Virol. 2013, 87, 13009-13019.
85. Li, H.; Gade, P.; Xiao, W.; Kalvakolanu, D.V. The interferon signaling network and transcription factor C/EBP-beta. Cell Mol. Immunol. 2007, 4, 407-418.
86. Johnson, P.F. Molecular stop signs: Regulation of cell-cycle arrest by C/EBP transcription factors. J. Cell Sci. 2005, 118, 2545-2555.
87. Nerlov, C. The C/EBP family of transcription factors: A paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007, 17, 318-324.
88. Sihto, H.; Joensuu, H. Tumor-infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus-associated cancer. Oncoimmunology 2012, 1, 1420-1421.
89. Harms, P.W.; Patel, R.M.; Verhaegen, M.E.; Giordano, T.J.; Nash, K.T.; Johnson, C.N.; Daignault, S.; Thomas, D.G.; Gudjonsson, J.E.; Elder, J.T., et al. Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. J. Invest. Dermatol. 2013, 133, 936-945.
90. Lauttia, S.; Sihto, H.; Kavola, H.; Koljonen, V.; Böhling, T.; Joensuu, H. Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma. Br. J. Cancer 2014, 110, 1446-1455.
91. Andea, A.A.; Coit, D.G.; Amin, B.; Busam, K.J. Merkel cell carcinoma: Histologic features and prognosis. Cancer 2008, 113, 2549-2558.
92. Paulson, K.G.; Iyer, J.G.; Tegeder, A.R.; Thibodeau, R.; Schelter, J.; Koba, S.; Schrama, D.; Simonson, W.T.; Lemos, B.D.; Byrd, D.R., et al. Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J. Clin. Oncol. 2011, 29, 1539-1546.
93. Wheat, R.; Roberts, C.; Waterboer, T.; Steele, J.; Marsden, J.; Steven, N.M.; Blackbourn, D.J. Inflammatory cell distribution in primary merkel cell carcinoma. Cancers 2014, 6, 1047-1064.
94. Sihto, H.; Böhling, T.; Kavola, H.; Koljonen, V.; Salmi, M.; Jalkanen, S.; Joensuu, H. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: A population-based study. Clin. Cancer Res. 2012, 18, 2872-2881.
95. Triozzi, P.L.; Fernandez, A.P. The role of the immune response in merkel cell carcinoma. Cancers (Basel) 2013, 5, 234-254.
96. Paulson, K.G.; Tegeder, A.; Willmes, C.; Iyer, J.G.; Afanasiev, O.K.; Schrama, D.; Koba, S.; Thibodeau, R.; Nagase, K.; Simonson, W.T., et al. Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma. Cancer Immunol. Res. 2014, 2, 1071-1079.
97. Afanasiev, O.K.; Yelistratova, L.; Miller, N.; Nagase, K.; Paulson, K.; Iyer, J.G.; Ibrani, D.; Koelle, D.M.; Nghiem, P. Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers. Clin. Cancer Res. 2013, 19, 5351-5360.
98. Lipson, E.J.; Vincent, J.G.; Loyo, M.; Kagohara, L.T.; Luber, B.S.; Wang, H.; Xu, H.; Nayar, S.K.; Wang, T.S.; Sidransky, D., et al. PD-L1 expression in the Merkel cell carcinoma microenvironment: Association with inflammation, Merkel cell polyomavirus and overall survival. Cancer Immunol. Res. 2013, 1, 54-63.
99. Griffiths, D.A.; Abdul-Sada, H.; Knight, L.M.; Jackson, B.R.; Richards, K.; Prescott, E.L.; Peach, A.H.; Blair, G.E.; Macdonald, A.; Whitehouse, A. Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling. J. Virol. 2013, 87, 13853-13867.
100. Clark, R.A.; Huang, S.J.; Murphy, G.F.; Mollet, I.G.; Hijnen, D.; Muthukuru, M.; Schanbacher, C.F.; Edwards, V.; Miller, D.M.; Kim, J.E., et al. Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J. Exp. Med. 2008, 205, 2221-2234.
101. Gehad, A.E.; Lichtman, M.K.; Schmults, C.D.; Teaque, J.E.; Calarese, A.W.; Jiang, Y.; Watanabe, R.; Clark, R.A. Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas. J. Invest Dermatol. 2012, 132, 2642-2651.
102. Afanasiev, O.K.; Nagase, K.; Simonson, W.; Vandeven, N.; Blom A.; Koelle, D.M.; Clark, R.; Nghiem, P. Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma. J. Invest. Dermatol. 2013, 133, 2065-2073.
103. Hayashi, H.; Tanaka, K.; Jay, F.; Khoury, G.; Jay, G. Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferon. Cell 1985, 43, 263-267.
104. Cromme, F.V.; van Bommel, P.F.; Walboomers, J.M.; Gallee, M.P.; Stern, P.L.; Kenemans, P.; Helmerhorst, T.J.; Stukart, M.J.; Meijer, C.J. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumors. Br. J. Cancer 1994, 69, 1176-1181.
105. Hill, A.; Jugovic, P.; York, I.; Russ, G.; Bennink, J.; Yewdell, J.; Ploeggh, H.; Johnson, D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995, 375, 411-415.
106. Koopman, L.A.; van Der Slik, A.R.; Giphart, M.J.; Fleuren, G.J. Human leukocyte antigen class I gene mutations in cervical cancer. J. Natl. Cancer Inst. 1999, 91, 1669-1677.
107. Haque, M.; Ueda, K.; Nakano, K.; Hirata, Y.; Parravicini, C.; Corbellino, M.; Yamanishi, K. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8. J. Gen. Virol. 2001, 82, 1175-1180.
108. Hansen, T.H.; Bouvier, M. MHC class I antigen presentation: Learning from viral evasion strategies. Nat. Rev. Immunol. 2009, 9, 503-513.
109. Chretien, A.S.; Le Roy, A.; Vey, N.; Prebet, T.; Blaise, D.; Fauriat, C.; Olive, D. Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity. Front. Immunol. 2014, 5, e122.
110. Riella, L.V.; Paterson, A.M.; Sharpe, A.H.; Chandraker, A. Role of the PD-1 pathway in the immune response. Am. J. Transplant. 2012, 12, 2575-2587.
111. Takenaka, H.; Kishimoto, S.; Shibagaki, T.; Nagata, M.; Yasuno, H. Merkel cell carcinoma with spontaneous regression: An immunohistochemical, ultrastructural, and TUNEL labeling study. Am. J. Dermatopathol. 1997, 19, 614-618.
112. Fujimoto, N.; Nakanishi, G.; Kabuto, M.; Nakano, T.; Eto, H.; Nakajima, H.; Sano, S.; Tanaka, T. Merkel cell carcinoma showing regression after biopsy: Evaluation of programmed cell death 1-positive cells. J. Dermatol. 2015, doi:10.1111/1346-8138.12805.
113. Arany, I.; Tyring, S.K. Status of cytokine and antigen presentation genes in Merkel cell carcinoma of the skin. J. Cutan. Med. Surg. 1998, 2, 138-141.
114. Lord, S.J.; Rajotte, R.V.; Korbutt, G.S.; Bleackley, R.C. Granzyme B: A natural born killer. Immunol. Rev. 2003, 193, 31-38.
115. Pahl, H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18, 6853-6866.
116. Hiroi, M.; Ohmori, Y. Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumor cell lines. Biochem. J. 2003, 376, 393-402.
117. Arora, R.; Shuda, M.; Guastafierro, A.; Feng, H.; Toptan, T.; Tolstov, Y.; Normolle, D.; Vollmer, L.L.; Vogt, A.; Dömling, A., et al. Survivin is a therapeutic target in Merkel cell carcinoma. Sci. Transl. Med. 2012, 4, 133-56.
118. Van Ghelue, M.; Khan, M.T.; Ehlers, B.; Moens, U. Genome analysis of the new human polyomaviruses. Rev. Med. Virol. 2012, 22, 354-377.
119. Youlden, D.R.; Youl, P.H.; Peter Soyer, H.; Fritschi, L.; Baade, P.D. Multiple primary cancers associated with Merkel cell carcinoma in Queensland, Australia, 1982-2011. J. Invest. Dermatol. 2014, 134, 2883-2889.
120. Mogha, A.; Fautrel, A.; Mouchet, N.; Guo, N.; Corre, S.; Adamski, H.; Watier, E.; Misery, L.; Galibert, M.D. Merkel cell polyomavirus small T-antigen mRNA level is increased following in vivo UV-radiation. PLOS ONE 2010, 5, e11423.
121. Sullivan, C.S.; Grundhoff, A.T.; Tevethia, S.; Pipas, J.M.; Ganem, D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005, 435, 682-686.
122. Cox, J.E.; McClure, L.V.; Goga, A.; Sullivan, C.S. Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses. Proc. Natl. Acad. Sci. USA 2015, 112, 1856-1861.
123. Bauman, Y.; Mandelboim, O. MicroRNA based immunoevasion mechanism of human polyomaviruses. RNA Biol. 2011, 8, 591-594.
124. Bauman, Y.; Nachmani, D.; Vitenshtein, A.; Tsukerman, P.; Drayman, N.; Stern-Ginossar, N.; Lankry, D.; Gruda, R.; Mandelboim, O. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 2011, 9, 93-102.
125. Lee, S.; Paulson, K.G.; Murchison, E.P.; Afanasiev, O.K.; Alkan, C.; Leonard, J.H.; Byrd, D.R.; Hannon, G.J.; Nghiem, P. Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas. J. Clin. Virol. 2011, 52, 272-275.
126. Groettrup, M.; Soza, A.; Eggers, M.; Kuehn, L.; Dick, T.P.; Schild, H. A role for the proteasome regulator PA28alpha in antigen presentation. Nature 1996, 381, 166-168.
127. Okkenhaug, K.; Bilancio, A.; Farjot, G.; Priddle, H.; Sancho, S.; Peskett, E.; Pearce, W.; Meek, S.E.; Salpekar, A.; Waterfield, M.D.; Smith, A.J.; Vanhaesevroeck, B. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 2002, 297, 1031-1034.
128. Yan, Q.; Sharma-Kuinkel, B.K.; Deshmukh, H.; Tsalik, E.L.; Cyr, D.D.; Lucas, J.; Woods, C.W.; Scott, W.K.; Sempowski, G.D.; Thaden, J.T., et al. Dusp3 and Psme3 Are Associated with Murine Susceptibility to Staphylococcus aureus Infection and Human Sepsis. PLOS Pathog. 2014, 10, e1004149.
129. Chen, C.J.; Cox, J.E.; Kincaid, R.P.; Martinez, A.; Sullivan, C.S. Divergent MicroRNA targetomes of closely related circulating strains of a polyomavirus. J. Virol. 2013, 87, 11135-11147.
130. Zhao, X.; Hsu, K.S.; Lim, J.H.; Bruggeman, L.A.; Kao, H.Y. α-Actinin 4 Potentiates Nuclear Factor κ-Light-chain-enhancer of Activated B-cell (NF-κB) Activity in Podocytes Independent of Its Cytoplasmic Actin Binding Function. J. Biol. Chem. 2015, 290, 338-349.
131. Jiao, S.; Zhang, Z.; Li, C.; Huang, M.; Shi, Z.; Wang, Y.; Song, X.; Liu, H.; Li, C.; Chen, M., et al. The kinase MST4 limits inflammatory responses through direct phosphorylation of the adaptor TRAF6. Nat. Immunol. 2015, 16, 246-257.
132. Kincaid, R.P.; Sullivan, C.S. Virus-Encoded microRNAs: An Overview and a Look to the Future. PLOS Pathog. 2012, 8, e1003018.
133. Lagatie, O.; Tritsmans, L.; Stuyver, L.J. The miRNA world of polyomaviruses. Virol. J. 2013, 10, e268.
134. Chen, C.J.; Cox, J.E.; Azarm, K.D.; Wylie, K.N.; Woolard, K.D.; Pesavento, P.A.; Sullivan, C.S. Identification of a polyomavirus microRNA highly expressed in tumors. Virology 2015, 476, 43-53.
135. Zhu, Y.; Haecker, I.; Yang, Y.; Gao, S.J.; Renne, R. γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr. Opin. Virol. 2013, 3, 266-275.
136. Renwick, N.; Cekan, P.; Masry, P.A.; McGeary, S.E.; Miller, J.B.; Hafner, M.; Li, Z.; Mihailovic, A.; Morozov, P.; Brown, M., et al. Multicolor microRNA FISH effectively differentiates tumor types. J. Clin. Invest. 2013, 123, 2694-2702.
137. Grundhoff, A.; Sullivan, C.S. Virus-encoded microRNAs. Virology 2011, 411, 325-343.
138. Cullen, B.R. MicroRNAs as mediators of viral evasion of the immune system. Nat. Immunol. 2013, 14, 205-210.
139. Fimia, G.M.; Corazzari, M.; Antonioli, M.; Piacentini, M. Ambra1 at the crossroad between autophagy and cell death. Oncogene 2013, 32, 3311-3318.
140. Sung, C.K.; Yim, H.; Andrews, E.; Benjamin, T.L. A mouse polyomavirus-encoded microRNA targets the cellular apoptosis pathway through Smad2 inhibition. Virology 2014, 468, 57-62.
141. Skalsky, R.L.; Cullen, B.R. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 2010, 64, 123-141.
142. Moens, U.; Seternes, O.M.; Johansen, B.; Rekvig, O.P. Mechanisms of transcriptional regulation of cellular genes by SV40 large T- and small t-antigens. Virus Genes 1997, 15, 135-154.
143. Cullen, B.R. Transcription and processing of human microRNA precursors. Mol. Cell 2004, 16, 861-865.
144. Seo, G.J.; Fink, L.H.; O’Hara, B.; Atwood, W.J.; Sullivan, C.S. Evolutionary conserved function of a viral microRNA. J. Virol. 2008, 82, 9823-9828.
145. Broekema, N.M.; Imperiale, M.J. miRNA regulation of BK polyomavirus replication during early infection. Proc. Natl. Acad. Sci. USA 2013, 110, 8200-8205.
146. Shuda, M.; Arora, R.; Kwun, H.J.; Feng, H.; Sarid, R.; Fernández-Figueras, M.T.; Tolstov, Y.; Gjoerup, O.; Mansukhani, M.M.; Swerdlow, S.H., et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int. J. Cancer 2009, 125, 1243-1249.
147. Brostoff, T.; Dela Cruz, F.N., Jr.; Church, M.E.; Woolard, K.D.; Pesavento, P.A. The raccoon polyomavirus genome and tumor antigen transcription are stable and abundant in neuroglial tumors. J. Virol. 2014, 88, 12816-12824.
148. Braconi, C.; Valeri, N.; Gasparini, P.; Huang, N.; Tacciolo, C.; Nuovo, G.; Suzuki, T.; Croce, C.M.; Patel, T. Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Clin. Cancer Res. 2010, 16, 957-966.
149. Wu, Y.H.; Hu, T.F.; Chen, Y.C.; Tsai, Y.N.; Tsai, Y.H.; Cheng, C.C.; Wang, H.W. The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. Blood 2011, 118, 2896-2905.
150. Bala, S.; Tilahun, Y.; Taha, O.; Alao, H.; Kodys, K.; Catalano, D.; Szabo, G. Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J. Transl. Med. 2012, 10, e151.
151. Lin, L.; Yin, X.; Hu, X.; Wang, Q.; Zheng, L. The impact of hepatitis B virus x protein and microRNAs in hepatocellular carcinoma: A comprehensive analysis. Tumor. Biol. 2014, 35, 11695-11700.
152. Ma, L.; Deng, X.; Wu, M.; Zhang, G.; Huang, J. Down-regulationof miRNA204 by LMP-1 enhances CDC2 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells. FEBS Lett. 2014, 588, 1562-1570.
153. Mansouri, S.; Pan, Q.; Blencowe, B.J.; Claycomb, J.M.; Frappier, L. Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer. J. Virol. 2014, 88, 11166-11177.
154. Vernin, C.; Thenoz, M.; Pinatel, C.; Gessain, A.; Gout, O.; Delfau-Larue, M.H.; Nazaret, N.; Legras-Lachuer, C.; Wattel, E.; Mortreux, F. HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs. Cancer Res. 2014, 74, 6082-6093.
155. Xie, H.; Lee, L.; Caramuta, S.; Höög, A.; Browaldh, N.; Björnhagen, V.; Larsson, C.; Lui, W.O. MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma. J. Invest. Dermatol. 2014, 134, 507-517.
156. Warburg, O. On respiratory impairment in cancer cells. Science 1956, 124, 269-270.
157. Zhao, Y.; Liu, H.; Riker, A.I.; Fodstad, O.; Ledoux, S.P.; Wilson, G.L.; Tan, M. Emerging metabolic targets in cancer therapy. Front. Biosci. 2011, 16, 1844-1860.
158. Kinnaird, A.; Michelakis, E.D. Metabolic modulation of cancer: A new frontier with great translational potential. J. Mol. Med. 2015, 93, 127-142.
159. George, A.; Girault, S.; Testard, A.; Delva, R.; Soulié, P.; Couturier, O.F.; Morel, O. The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: A retrospective study of 66 scans from a single institution. Nucl. Med. Commun. 2014, 35, 282-290.
160. Kitagawa, K.; Nishino, H.; Iwashima, A. Analysis of hexose transport in untransformed and sarcoma virus-transformed mouse 3T3 cells by photoaffinity binding of cytochalasin B. Biochim. Biophys Acta 1985, 821, 63-66.
161. Bravard, A.; Beaumatin, J.; Luccioni, C.; Fritsch, P.; Lefrançois, D.; Thenet, S.; Adolphe, M.; Dutrillaux, B. Chromosomal, mitochondrial and metabolic alterations in SV40-transformed rabbit chondrocytes. Carcinogenesis 1992, 13, 767-772.
162. Lachaise, F.; Martin, G.; Drougard, C.; Perl, A.; Vuillaume, M.; Wegnez, M.; Sarasin, A.; Daya-Grosjean, L. Relationship between posttranslational modification of transaldolase and catalase deficiency in UV-sensitive repair-deficient xeroderma pigmentosum fibroblasts and SV40-transformed human cells. Free Radic. Biol. Med. 2001, 30, 1365-1373.
163. Noch, E.; Sariyer, I.K.; Gordon, J.; Khalili, K. JC virus T-antigen regulates glucose metabolic pathways in brain tumor cells. PLOS ONE 2012, 7, e35054. doi:10.1371/journal.pone.0035054.
164. Duracher, D.; Wyczechowska, D.; Wilk, A.; Lassak, A.; Zea, A.; Estrada, J.; Reis, K. The Effects of JCV T-antigen on Tumor Cell Metabolism. Available online: http://www.medschool.lsuhsc.edu/cancer_center/docs/Dustin%20Duracher%20Poster%2036x60.pdf (accessed on 10 March 2015).
165. Ramanathan, A.; Wang, C.; Schreiber, S.L. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. USA 2005, 102, 5992-5997.
166. Yuan, H.; Veldman, T.; Rundell, K.; Schlegel, R. Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. J. Virol. 2002, 76, 10685-10691.
167. Elstrom, R.L.; Bauer, D.E.; Buzzai, M.; Karnauskas, R.; Harris, M.H.; Plas, D.R.; Zhuang, H.; Cinalli, R.M.; Alavi, A.; Rudin, C.M.; Thompson, C.B. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64, 3892-3899.
168. Rodriguez-Viciana, P.; Collins, C.; Fried, M. Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control. Proc. Natl. Acad. Sci. USA 2006, 103, 19290-19295.
169. Sontag, E.; Fedorov, S.; Kamibayashi, C.; Robbins, D.; Cobb, M.; Mumby, M. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 1993, 75, 887-897.
170. Agnetti, G.; Maraldi, T.; Giorentini, D.; Giordano, E.; Prata, C.; Hakim, G.; Muscari, C.; Guarnieri, C.; Caldarera, C.M. Activation of glucose transport during simulated ischemia in H9c2 cardiac myoblasts is mediated by protein kinase C isoforms. Life Sci. 2005, 78, 264-270.
171. Madan, E.; Gogna, R.; Bhatt, M.; Pati, U.; Kuppusamy, P.; Mahdi, A.A. Regulation of glucose metabolism by p53: Emerging new roles for the tumor suppressor. Oncotarget 2011, 2, 948-957.
172. Shivakumar, C.V.; Das, G.C. Interaction of human polyomavirus BK with the tumor-suppressor protein p53. Oncogene 1996, 13, 323-332.
173. Staib, C.; Pesch, J.; Gerwig, R.; Gerber, J.K.; Brehm, U.; Stangl, A.; Grummt, F. p53 inhibits JC virus DNA replication in vivo and interacts with JC virus large T-antigen. Virology 1996, 219, 237-246.
174. Kenific, C.M.; Debnath, J. Cellular and metabolic functions for autophagy in cancer cells. Trends Cell Biol. 2015, 25, 37-45.
175. Silva, L.M.; Jung, J.U. Modulation of the Autophagy Pathway by Human Tumor Viruses. Semin. Cancer Biol. 2013, 23, 323-328.
176. Bouley, S.J.; Maginnis, M.S.; Derdowski, A.; Gee, G.V.; O’Hara, B.A.; Nelson, C.D.; Bara, A.M.; Atwood, W.J.; Dugan, A.S. Host cell autophagy promotes BK virus infection. Virology 2014, 456, 87-95.
177. Kumar, S.H.; Rangarajan, A. Simian virus 40 small T antigen activates AMPK and triggers autophagy to protect cancer cells from nutrient deprivation. J. Virol. 2009, 83, 8565-8574.
178. Rundell, K.; Major, E.O.; Lampert, M. Association of cellular 56,000- and 32,000-molecular-weight protein with BK virus and polyoma virus t-antigens. J. Virol. 1981, 37, 1090-1093.
179. Bollag, B.; Hofstetter, C.A.; Reviriego-Mendoza, M.M.; Frisque, R.J. JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity. PLOS ONE 2010, 5, e10606.
180. Shuda, M.; Kwun, H.J.; Feng, H.; Chang, Y.; Moore, P.S. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J. Clin. Invest. 2011, 121, 3623-3634.
181. Berrios, C.; Jung, J.; Primi, B.; Wang, M.; Pedamallu, C.; Duke, F.; Marcelus, C.; Cheng, J.; Garcea, R.L.; Meyerson, M.; DeCaprio, J.A. Malawi polyomavirus is a prevalent human virus that interacts with known tumor suppressors. J. Virol. 2015, 89, 857-862.
182. Kwun, H.J.; Shuda, M.; Camacho, C.J.; Gamper, A.M.; Thant, M.; Chang, Y.; Moore, P.S. Restricted Protein Phosphatase 2A Targeting by Merkel Cell Polyomavirus Small T Antigen. J. Virol. 2015, 89, 4191-4200.
183. Basile, A.; Darbinian, N.; Kaminski, R.; White, M.K.; Gentilella, A.; Turco, M.C.; Khalili, K. Evidence for modulation of BAG3 by polyomavirus JC early protein. J. Gen. Virol. 1999, 90, 1629-1640.
184. Sariyer, I.K.; Merabova, N.; Patel, P.K.; Knezevic, T.; Rosati, A.; Turco, M.C.; Khalili, K. Bag3-induced autophagy is associated with degradation of JCV oncoprotein, T-Ag. PLOS ONE 2012, 7, e45000.
185. Ribbens, J.J.; Moser, A.B.; Hubbard, W.C.; Bongarzone, E.R.; Maegawa, G.H. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease. Mol. Genet. Metab. 2014, 111, 172-183.
186. Meckes, D.G., Jr.; Raab-Traub, N. Microvesicles and viral infection. J. Virol. 2011, 85, 12844-12854.
187. Brinton, L.T.; Sloane, H.S.; Kester, M.; Kelly, K.A. Formation and role of exosomes in cancer. Cell Mol. Life Sci. 2015, 72, 659-671.
188. Schorey, J.S.; Cheng, Y.; Singh, P.P.; Smith, V.L. Exosomes and other extracellular vesicles in host-pathogen interactions. EMBO Rep. 2015, 16, 24-43.
189. Ramakrishnaiah, V.; Thumann, C.; Fofana, I.; Habersetzer, F.; Pan, Q.; de Ruiter, P.E.; Willemsen, R.; Demmers, J.A.; Stalin Raj, V.; Jenster, G., et al. Exosome-mediated transmission of hepatitis C virus between hepatoma Huh7.5 cells. Proc. Natl. Acad. Sci. USA 2013, 110, 13109-13113.
190. Jaworski, E.; Narayanan, A.; van Duyne, R.; Shabbeer-Meyering, S.; Iordanskiy, S.; Saifuddin, M.; Das, R.; Afonso, P.V.; Sampey, G.C.; Chung, M., et al. Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein. J. Biol. Chem. 2014, 289, 22284-22305.
191. Zhao, X.; Wu, Y.; Duan, J.; Ma, Y.; Shen, Z.; Wei, L.; Cui, X.; Zhang, J.; Xie, Y.; Liu, J. Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC-MS/MS. J. Proteome Res. 2014, 13, 5391-5402.
192. Lee, T.H.; Chennakrishnaiah, S.; Audemard, E.; Montermini, L.; Meehan, B.; Rak, J. Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells. Biochem. Biophys. Res. Commun. 2014, 451, 295-301.
193. Giovannelli, I.; Martelli, F.; Repice, A.; Massacesi, L.; Azzi, A.; Giannecchini, S. Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. J. Neurovirol. 2015, doi:10.1007/s13365-015-0325-3.
194. Meckes, D.G., Jr.; Shair, K.H.; Marquitz, A.R.; Kung, C.P.; Edwards, R.H.; Raab-Traub, N. Human tumor virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. USA 2010, 107, 20370-20375.
195. Dreux, M.; Garaigorta, U.; Boyd, B.; Décembre, E.; Chung, J.; Whitten-Bauer, C.; Wieland, S.; Chisari, F.V. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 2012, 12, 558-570.
196. Chugh, P.E.; Sin, S.H.; Ozgur, S.; Henry, D.H.; Menezes, P.; Griffith, J.; Eron, J.J.; Damania, B.; Dittmer, D.P. Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. PLOS Pathog. 2013, 9, e1003484.
197. Meckes, D.G., Jr.; Gunawardena, H.P.; Dekroon, R.M.; Heaton, P.R.; Edwards, R.H.; Ozgur, S.; Griffith, J.D.; Damania, B.; Raab-Traub, N. Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc. Natl. Acad. Sci. USA 2013, 110, E2925-E2933.
198. Velders, M.P.; Macedo, M.F.; Provenzano, M.; Elmishad, A.G.; Holzhütter, H.G.; Carbone, M.; Kwast, W.M. Human T cell responses to endogenously presented HLA-A*0201 restricted peptides of Simian virus 40 large T antigen. J. Cell Biochem. 2001, 82, 155-162.
199. Vlastos, A.; Andreasson, K.; Tegerstedt, K.; Holländerová, D.; Heidari, S.; Forstová, J.; Ramqvist, T.; Dalianis, T. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model. J. Med. Virol. 2003, 70, 293-300.
200. Lowe, D.B.; Shearer, M.H.; Tarbox, J.A.; Kang, H.S.; Jumper, C.A.; Bright, R.K.; Kennedy, R.C. In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization. Virology 2005, 332, 28-37.
201. Zeng, Q.; Gomez, B.P.; Viscidi, R.P.; Peng, S.; He, L.; Ma, B.; Wu, T.C.; Hung, C.F. Development of a DNA vaccine targeting Merkel cell polyomavirus. Vaccine 2012, 30, 1322-1329.
202. Sospedra, M.; Schippling, S.; Yousef, S.; Jelcic, I.; Bofill-Mas, S.; Planas, R.; Stellmann, J.P.; Demina, V.; Cinque, P.; Garcea, R., et al. Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.Clin. Infect Dis. 2014, 59, 1588-1592.
203. Willmes, C.; Adam, C.; Alb, M.; Völkert, L.; Houben, R.; Becker, J.C.; Schrama, D. Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens. Cancer Res. 2012, 72, 2120-2128.
204. Nakajima H.; Takaishi, M.; Yamamoto, M.; Kamijima, R.; Kodama, H.; Tarutani, M.; Sano, S. Screening of the specific polyoma virus as diagnostic and prognostic tools for Merkel cell carcinoma. J. Dermatol. Sci. 2009, 56, 211-213.
205. Biver-Dalle, C.; Nguyen, T.; Touzé, A.; Saccomani, C.; Penz, S.; Cunat-Peultier, S.; Riou-Gotta, M.O.; Humbert, P.; Coursaget, P.; Aubin, F. Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus. Acta Oncol. 2011, 50, 479-480.
206. Chapuis, A.G.; Afanasiev, O.K.; Iyer, J.G.; Paulson, K.G.; Parvathaneni, U.; Hwang, J.H.; Lai, I.; Roberts, I.M.; Sloan, H.L.; Bhatia, S., et al. Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I. Cancer Immunol. Res. 2014, 2, 27-36.
207. Hata, Y.; Matsuka, K.; Ito, O.; Matsuda, H.; Furuichi, H.; Konstantinos, A.; Nuri, B. Two cases of Merkel cell carcinoma cured by intratumor injection of natural human tumor necrosis factor. Plast Reconstr. Surg. 1997, 99, 547-553.
208. Lampreave, J.L.; Bénard, F.; Alavi, A.; Jimeneze-Hoyuela, J.; Fraker, D. PET evaluation of therapeutic limb perfusion in Merkel’s cell carcinoma. J. Nucl. Med. 1998, 39, 2087-2090.
209. Olieman, A.F.; Liénard, D.; Eggermont, A.M.; Kroon, B.B.; Lejeune, F.J.; Hoekstra, H.J.; Koops, H.S. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: A multicenter study. Arch. Surg. 1999, 134, 303-307.
210. Krishna, S.M.; Kim, C.N. Merkel cell carcinoma in a patient treated with adalimumab: Case report. Cutis 2011, 87, 81-84. Erratum in Cutis 2011, 87, 185.
211. Linn-Rasker, S.P.; van Albada-Kuipers, G.A.; Dubois, S.V.; Janssen, K.; Zweers, P.G. Merkel cell carcinoma during treatment with TNF-alpha inhibitors: Coincidence or warning? Ned. Tijdschr. Geneeskd. 2012, 156, A44-A64.
212. Reiss, K.A.; Forde, P.M.; Brahmer, J.R. Harnessing the power of the immune system via blockade of PD-1 and PD-L1: A promising new anticancer strategy. Immunotherapy 2014, 6, 459-475.
213. Orba, Y.; Sawa, H.; Iwata, H.; Tanaka, S.; Nagashima, K. Inhibition of virus production in JC virus-infected cells by postinfection RNA interference. J. Virol. 2004, 78, 7270-7273.
214. Sabbioni, S.; Callegari, E.; Spizzo, R.; Veronese, A.; Altavilla, G.; Corallini, A.; Negrini, M. Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag. Cancer Gene Ther. 2007, 14, 297-305.
215. Houben, R.; Shuda, M.; Weinkam, R.; Schrama, D.; Feng, H.; Chang, Y.; Moore, P.S.; Becker, J.C. Merkel cell polyoma virus-infected Merkel cell carcinoma cells require expression of viral T antigens. J. Virol. 2010, 84, 7064-7072.
216. Angermeyer, S.; Hesbacher, S.; Becker, J.C.; Schrama, D.; Houben, R. Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen. J. Invest Dermatol. 2013, 133, 2059-2064.
217. Lin, M.C.; Wang, M.; Fang, C.Y.; Chen, P.L.; Shen, C.H.; Chang, D. Inhibition of BK virus replication in human kidney cells by BK virus large tumor antigen-specific shRNA delivered by JC virus-like particles. Antiviral Res. 2014, 103, 25-31.
218. Hartman, Z.C.; Wei, J.; Glass, O.K.; Guo, H.; Lei, G.; Yang, X.Y.; O ada, T.; Hobeika, A.; Delcayre, A.; Le Pecq, J.B.; Morse, M.A.; Clay, T.M.; Lyerly, H.K. Increasing vaccine potency through exosome antigen targeting. Vaccine 2011, 29, 9361-9367.
219. Shuda, M.; Feng, H.; Kwun, H.J.; Rosen, S.T.; Gjoerup, O.; Moore, P.S.; Chang, Y. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl. Acad. Sci. USA 2008, 105, 16272-16277.